OEV Partners exists to support and enable the emerging, revolutionary mental health paradigm shift now made possible by global drug law reform.
We believe that new treatments using psychedelics such as psilocybin, MDMA, LSD, ibogaine and ketamine, will soon be as indispensable in mental healthcare as anaesthetic or antibiotics are in surgery – and so do increasing numbers of policy makers, medical professionals, and service providers worldwide.
Our goal is to help this dynamic and complex sector grow responsibly through research-based advocacy and campaigning, education, continuous improvement and smart, people-centred service design. That means putting the needs of service users first – in everything we do, so as many people as possible benefit as treatments and therapies come online.
What we do
Policy, Advocacy
and Campaigning
We create powerful narratives around areas of need that put lived experience at the centre, devising incisive policy that will deliver real change.
Research
and Data Analysis
Understanding is key, we use in-depth research and precise data analysis to provide compelling support for campaigns and policy.
Service Design
and Improvement
Real change means services designed with those with the need at the centre. We work with providers to ensure new services and treatments deliver enduring benefits.
Event Planning
and Management
We use in person and virtual events to inform, educate, and motivate and create and sustain a network of people and organisations driving change.
‘Ethics, Culture and Mental Health :
A Need for New Thinking’
Click the video below to hear about our most recent seminar, held on April 26 2024, and organized in collaboration with
The University of Law and Cranstoun. Hear directly from OEV directors Neil Woods and Chris Jenkins on reasons for
holding the event and about their wider plans around addressing the mental health crisis in society.